Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver.
Li X, Tao J, Cigliano A, Sini M, Calderaro J, Azoulay D, Wang C, Liu Y, Jiang L, Evert K, Demartis MI, Ribback S, Utpatel K, Dombrowski F, Evert M, Calvisi DF, Chen X.
Li X, et al. Among authors: liu y.
Oncotarget. 2015 Apr 30;6(12):10102-15. doi: 10.18632/oncotarget.3546.
Oncotarget. 2015.
PMID: 25826091
Free PMC article.